首页 | 本学科首页   官方微博 | 高级检索  
检索        

特利加压素治疗肝叶切除术后肝肾综合征的疗效分析
引用本文:肖俊.特利加压素治疗肝叶切除术后肝肾综合征的疗效分析[J].临床外科杂志,2011,19(7):471-472.
作者姓名:肖俊
作者单位:武汉市第十一医院普外科,430015
摘    要:目的分析特利加压素治疗肝叶切除术后肝肾综合征(HRS)的临床疗效。方法42例患者分为A组和B组,在综合治疗的基础上,A组给予利尿合剂和白蛋白治疗,B组给予特利加压素和白蛋白治疗,疗程均为7d。治疗期间观察患者一般临床症状、尿量、血清尿素氮和肌酐以及并发症等指标。结果疗程结束后,A组尿量治疗前为(663±249)ml/d,治疗后为(987±354)ml/d,差异有统计学意义(P〈0.05),尿素氮和肌酐较治疗前有所下降,但差异无统计学意义(P〉0.05);B组尿量治疗前为(598±324)ml/d,治疗后为(1956±875)ml/d,尿素氮由(19.4±5.8)mmol/L下降至(10.5±4.3)mmol/L,肌酐由(231.2±69.8)μmol/L下降至(128.9±35.2)μmol/L,治疗前、后差异均有统计学意义(P〈0.05);治疗前两组的尿量、尿素氮和肌酐差异无统计学意义(P〉0.05),治疗后与A组比较,B组变化更明显,差异有统计学意义(P〈0.05);两组的并发症差异无统计学意义。结论特利加压素治疗肝叶切除术后HRS优于常用的利尿合剂,具有良好的疗效。

关 键 词:特利加压素  肝肾综合征  肝叶切除术  白蛋白

Therapeutic efficacy of terlipressin for hepatorenal syndrome after liver lobectomy
XIAO Jun.Therapeutic efficacy of terlipressin for hepatorenal syndrome after liver lobectomy[J].Journal of Clinical Surgery,2011,19(7):471-472.
Authors:XIAO Jun
Institution:XIAO Jun. (Department of General Surgery, Wuhan 11 th Hospital, Wuhan 430015, China)
Abstract:Objective To analyze the clinical therapeutic efficacy of terlipressin in management of hepatorenal syndrome ( HRS ) after liver lobectomy. Methods Forty - two patients were divided into group A and group B. Based on comprehensive treatment,traditional diuresis drug,dopamine and albumin were used in group A,while terlipressin and albumin were used in group B. Duration of treatment was 7 days in both groups A and B. The common clinical symptoms,urine output,blood urea nitrogen and creati- nine, complications were observed during treatment. Results After the treatment, the urine output, from (663 ± 249 ) to (987 ± 354) ml/24 h, was increased significantly ( P 〈 0.05 ) and the blood urea nitrogen and creatinine were decreased but there was no significant difference in group A(P 〉0.05 ). In group B, the urine output, from ( 598 ± 324 ) to ( 1956 ± 875 ) mL/24 h, was increased significantly ( P 〈 0.05 ), and both blood urea nitrogen from ( 19.4 ± 5.8 ) to ( 10.5 ± 4.3 ) retool/l, and creatinine from ( 231.2 ± 69.8 ) μmol/L to( 128.9 ± 35.2 )μmol/L were decreased sigrfifieantly( P 〈 0.05 ). There was no statistically sig- nificant difference between groups A and B in urine output,blood urea nitrogen and ereatinine(P 〉0.05) before treatment,but the efficacy index of group B was better than that of group A after treatment (P 〈 0.05 ). There was no significant difference in complications between groups A and B ( P 〉 0.05). Conclusion Compared with traditional diuresis drug and dopamine,terlipressin is more effective on HRS.
Keywords:terlipressin  bepatoreual syndrome  liver lobeetomy  albumin
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号